Dr. Sanjay Gupta: Why Haven’t We Cured the Common Cold?
The average person gets two to four colds a year. With all the missed school and work, that adds up to an economic impact of…
Thought Leader: Sanjay Gupta
The king is dead, long live the king: Sharpless vows to continue Gottlieb era at FDA
By Scott Gottlieb (Original source Fierce Biotech)
“Scott Gottlieb’s relatively short two-year tenure as the FDA’s head has ended, and we have a new man at the helm: Ned Sharpless. However, he used his first official talk to ensure we all know he’s not looking to tear up Gottlieb’s legacy.
Gottlieb, in fact, denied to reporters at the start of the year that he was leaving, but a few short months later he announced he was doing exactly that (citing commuting times), and then preceded to have the world’s longest goodbye tour. Fitting, I suppose, for a rock’n’roll FDA commissioner.
Gottlieb was praised by many in the bio Twitter sphere, as well as by President Donald Trump, the man who appointed him as FDA commissioner. Some areas, though, namely the opioid crisis and the surge in an anti-vaxxer movement, which has also seen a related spike in measles cases in the U.S., are still areas the FDA must get a grip on.”
Click here to see more
Relevant and recent posts
Erika Ayers Badan: How to Keep Creativity Alive
Hi! Ever felt like you’re on a Disney ride through every big-company headache imaginable? Think lawyers, bankers, finance goons, stale conference rooms, staid conversations and…
Thought Leader: Erika Ayers Badan
Chris Miller: Trump’s Nvidia Chip Decision Lands Hard
In a new article, “Allowing China access to advanced semiconductors puts national security and U.S. AI industry at risk,”Chris Miller — author of Chip War…
Thought Leader: Chris Miller
More with this speaker
Scott Gottlieb on China’s biotech strategy
Thought Leader: Scott Gottlieb
Scott Gottlieb: China’s edge over U.S. biotech
Thought Leader: Scott Gottlieb